Skip to main content
Clinical Trials/NCT02089139
NCT02089139
Terminated
Not Applicable

Intradiscal Injection of Gelified Ethanol for the Treatment of Discogenic Back Pain

University Hospital, Limoges1 site in 1 country40 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Discogenic Back Pain
Sponsor
University Hospital, Limoges
Enrollment
40
Locations
1
Primary Endpoint
Visual Analog Scale (VAS)
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

Discogenic low back pain is the most common form of chronic low back pain. Its diagnosis is mainly based on MR imaging, showing MODIC I or II changes in patients with concordant symptomatology. The treatment of discogenic low back pain is nevertheless difficult: intradiscal therapies (corticosteroids, methylene blue, radiofrequency) have a limited efficacy, and surgical procedures (arthrodesis or disc replacement) are a final recourse with notable risk of side-effects.

In this study, the efficacy of intradiscal injection of gelified ethanol (DiscoGel) in patients with disabling discogenic pain is assessed.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
September 2018
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Limoges
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • MR imaging : MODIC 1or MODIC 2 changes limited to one single lumbar disc;
  • X rays: normal disc height, no instability;
  • Back pain for at least 3 months, without argument for another etiology;
  • Mean pain on 5 days VAS ≥ 5

Exclusion Criteria

  • age \<18 years or \> 50 ; concomitant radicular pain ;
  • psychiatric pathology that may modify the perception or the evolution of pain;
  • MR imaging: multi-level discopathy, MODIC 3 changes;
  • X ray: loss of disc height \> 50%, segmental instability;
  • previous history of lumbar surgery with or without instrumentation.

Outcomes

Primary Outcomes

Visual Analog Scale (VAS)

Time Frame: Six months after the procedure.

Mean pain intensity score on a Visual Analog Scale (VAS), six months after the procedure.

Secondary Outcomes

  • Oswestry Disability Index (ODI)(one month, three months, six months and 1 year after the procedure)
  • Euroqol score(month, three months, six months and 1 year after the procedure)
  • Visual Analog Scale (VAS),(one month, three months, six months and 1 year after the procedure)

Study Sites (1)

Loading locations...

Similar Trials